NP / PA
Savitsky, Kristen
Savitsky, Kristen was paid $293K by Medicaid between Jan 2018 and Mar 2023, across 13 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 35% of everything it billed.
33Billing provider infoSAVITSKY, KRISTEN
NORTH ADAMS, MA 01247
NORTH ADAMS, MA 01247
33aNPI1770909111assigned 03/10/2014
33bProvider typeFamily Nurse Practitioner
28Total paid$293K
24GClaims5,371
24DCodes billed13
24AFirst – last monthJan 2018 – Mar 2023
Compared with peers
Next to other Family Nurse Practitioner providers in Massachusetts
Rank by total paid#16 of 327
Median peer was paid$5K
This provider vs. median55×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 106 | $5K | |
| 2019 | 465 | $28K | |
| 2020 | 880 | $42K | |
| 2021 | 1,553 | $81K | |
| 2022 | 1,866 | $104K | |
| 2023 | 501 | $33K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 35% | 1,085 | 1,038 | $102K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 32% | 1,725 | 1,653 | $94K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 18% | 1,038 | 1,017 | $52K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 6.8% | 241 | 238 | $20K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2.2% | 269 | 262 | $6K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.0% | 195 | 192 | $6K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.3% | 103 | 103 | $4K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | <1% | 323 | 320 | $3K |
| 0002A | <1% | 44 | 44 | $2K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 160 | 160 | $2K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 69 | 69 | $839.32 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 78 | 39 | $727.87 |
1 more codes
| 96127 | <1% | 41 | $657.28 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.